Given the extensively characterized role of PDGFRA in cell proliferation and in particular in glioma, it is reasonable to propose that the reduction in Pdgfra expression upon Atm loss contributes to the reduced tumorigenic potential observed. The gene discussed is PDGFRA; the disease is glioma.